Fungal infections affect over 1 billion people, with mortality rates estimated at 1-2 million annually. Advancements in modern medicine, including bone marrow and solid organ transplants or anti-neoplastic chemotherapy have induced a major uptick in the incidence of opportunistic fungal infections.

Market Analysis and Insights: Global Fungal Testing Kit Market
In 2020, the global Fungal Testing Kit market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Fungal Testing Kit Scope and Market Size
The global Fungal Testing Kit market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Fungal Testing Kit market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Molecular Test
Chromogenic Test
Others

Segment by Application
Diagnostic Laboratory
Hospitals
Pharmaceutical Companies
Research and Academic Institutes

By Company
Merck KGaA
Thermo Fisher Scientific
bioMerieux SA
ELITech Group
PerkinElmer
GenMark Diagnostics Inc.
Norgen Biotek
C.P.M Diagnostic Research SAS
Biomed Diagnostics
PCRmax
Roche
Hologic
Bioquochem

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE